Study on proper use of the incretin related drugs and effects on renal function.

Study on proper use of the incretin related drugs and effects on renal function. - Super REAL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031821

Enrollment

2000

Registered

2018-03-20

Start date

2017-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients who used incretin related drugs in our hospital from 1st December 2009 to 31st May 2017.

Exclusion criteria

Exclusion criteria: Cases in which the test results were lost due to the transfer.

Design outcomes

Primary

Measure	Time frame
eGFR change	—

Countries

Japan

Contacts

Public ContactKanori Iwamatsu

Tokai University School of Medicine Division of Nephrology, Endocrinology and Metabolism

k-iwamtsu@tsc.u-tokai.ac.jp0463-93-1121

Outcome results